Cosmetics and Pregnancy (PERICOS)

University Hospital, Clermont-Ferrand

Status: Unknown

Conditions: Pregnancy

Treatments: Other: Group discussions

Study type: Observational

Funder types: Other

Identifiers

NCT03283189

CHU-350

Details and patient eligibility

About

The use of cosmetics is an important source of exposure to many chemicals including endocrine disruptors. Recently, national and international scientific recommendations have been issued to limit exposure to chemicals during pregnancy. However, the perception and the use of cosmetics by pregnant women is still little studied. The objectives of the PERICOS study are to identify the risk perception and the attitudes regarding cosmetic's use by the pregnant women.

Understanding the risk perception, the knowledge, attitudes and expectations of women about the use of cosmetics during pregnancy will help to set up effective strategies to improve prevention of chemical exposure.

Full description

A qualitative study of 60 pregnant women using six focus groups (9-11 pregnant women per group) was implemented study in Auvergne Region, France. Six focus groups will be conducted until data saturation.

The women will be recruited from the Clermont-Ferrand University Hospital (maternity type III - 2 groups), the private clinic in Beaumont (maternity type II - 2 groups), the Saint-Flour hospital center (maternity type I - 1 group), and from liberal health professionals (1 group).

If a women is found to be eligible, she will be invited to participate in the study. The focus group discussions will be conducted in a private room in the maternity of the women. They will last approximately 2 hours and will be led by an interviewer using an interview grid.

All interviews will be audio-recorded, transcribed, coded and computerized for analysis with the NVIVO v11 software.

Enrollment: 60 estimated patients

Sex: Female

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• • Pregnant women between 22 (≥ 22 weeks) et ≤ 39 weeks of gestation;
• Obstetric management in the Réseau de Santé en Périnatalité d'Auvergne (RSPA);
• At least 18 years;
• Understanding and speaking French;
• And giving their signed agreement of participation.

Exclusion criteria

• Refusal to participate or to be registered during the collective interview;
• Women with fetal death in utero or whose fetus or fetuses have a malformation;
• Women with psychiatric disorders, mental confusion or language disorders making impossible the interview;
• Women with chronic dermatological pathology requiring dermatological care (eczema, psoriasis, etc.).

Trial design

60 participants in 6 patient groups

Group 1

Description:

Pregnancy follow-up in the only maternity type III of the region (CHU) and in an urban area (around Clermont-Ferrand)

Treatment:

Other: Group discussions

Group 2

Description:

Pregnancy follow-up in the only maternity type III of the region (CHU) and in an urban area (around Clermont-Ferrand)

Treatment:

Other: Group discussions

Group 3

Description:

Pregnancy follow-up in the only private maternity (type II) of the region and in an urban area (around Clermont-Ferrand)

Treatment:

Other: Group discussions

Group 4

Description:

Pregnancy follow-up in the only private maternity (type II) of the region and in an urban area (around Clermont-Ferrand)

Treatment:

Other: Group discussions

Group 5

Description:

Pregnancy follow-up in a type I maternity and in a rural area (around Saint-Flour)

Treatment:

Other: Group discussions

Group 6

Description:

Liberal follow-up of pregnancy